Adverse Birth Outcomes Up With Medically Assisted Reproduction
MONDAY, Jan. 28, 2019 -- Children born by medically assisted reproduction have an increased risk for adverse birth outcomes; however, the increased risk appears to be attributable to other factors, according to a study published online Jan. 14 in The Lancet.
Alice Goisis, Ph.D., from the London School of Economics and Political Science, and colleagues used data from Finnish administrative registers and examined birth weight, gestational age, risk for low birth weight, and risk for preterm birth for children conceived by medically assisted reproduction and children conceived naturally.
Four percent of children (2,776 children) in the sample were conceived by medically assisted reproduction between 1995 and 2000; 1,245 children were included in a sibling comparison. The researchers found that outcomes were worse for children conceived by medically assisted reproduction compared with those conceived naturally for all outcomes, even after adjustment for observed child and parent characteristics (e.g., −60 g difference in birth weight [95 percent confidence interval, −86 to −34 g]; 2.15 percentage point increased risk for preterm delivery [95 percent confidence interval, 1.07 to 3.24]). The gap in birth outcomes was attenuated in the sibling comparison (e.g., −31 g difference in birth weight [95 percent confidence interval, −85 to 22 g] and 1.56 percentage point increased risk for preterm delivery [95 percent confidence interval, −1.26 to 4.38]).
"These findings support the argument that medically assisted reproduction treatments per se have little or no effect on the risk of adverse birth outcomes," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: January 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.